Transchem Ltd (TRANSCHEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 538955,
    "name": "Transchem",
    "stock_name": "Transchem",
    "full_name": "Transchem Ltd",
    "name_url": "stocks-analysis/transchem",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "173.90",
    "chg": -3.5,
    "chgp": "-1.97%",
    "dir": -1,
    "prev_price": "177.40",
    "mcapval": "217.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 500422,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE019B01010",
    "curr_date": "Mar 05",
    "curr_time": "",
    "bse_nse_vol": "1 ",
    "exc_status": "Active",
    "traded_date": "Mar 05, 2026",
    "traded_date_str": "2026 03 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/transchem-538955-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Transchem Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-downgraded-to-strong-sell-amid-weak-financials-and-mixed-technical-signals-3865851",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TranschemLtd_mojoScore_3865851.png",
        "date": "2026-03-03 08:07:39",
        "description": "Transchem Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 2 March 2026, reflecting a complex interplay of deteriorating financial fundamentals, cautious valuation metrics, and mixed technical signals. Despite impressive long-term returns, recent quarterly losses and weakening operational metrics have raised concerns among analysts, prompting a reassessment of the stock’s outlook."
      },
      {
        "title": "Transchem Ltd Upgraded from Strong Sell to Sell Amid Mixed Technical and Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-upgraded-from-strong-sell-to-sell-amid-mixed-technical-and-financial-signals-3852138",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TranschemLtd_mojoScore_3852138.png",
        "date": "2026-02-24 08:04:10",
        "description": "Transchem Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by improved technical indicators despite ongoing financial challenges. The pharmaceutical and biotechnology company’s recent performance reveals a complex picture where technical momentum contrasts with deteriorating fundamentals, prompting a nuanced reassessment of its investment appeal."
      },
      {
        "title": "Transchem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-is-rated-strong-sell-3848082",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TranschemLtd_mojoScore_3848082.png",
        "date": "2026-02-20 10:10:49",
        "description": "Transchem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 20 February 2026, providing investors with the most up-to-date insight into the stock’s fundamentals and market performance."
      },
      {
        "title": "Transchem Ltd Investment Rating Upgraded to Sell on Technical Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-investment-rating-upgraded-to-sell-on-technical-improvements-3827980",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TranschemLtd_mojoScore_3827980.png",
        "date": "2026-02-09 08:03:07",
        "description": "Transchem Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 6 February 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing financial challenges, with the MarketsMOJO Mojo Score adjusting to 31.0. Investors are advised to consider the detailed analysis across quality, valuation, financial trends, and technical indicators before making decisions."
      },
      {
        "title": "Are Transchem Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-transchem-ltd-latest-results-good-or-bad-3826811",
        "imagepath": "",
        "date": "2026-02-07 19:17:55",
        "description": "Transchem Ltd's latest financial results for Q2 FY26 reveal significant operational challenges, primarily characterized by a complete absence of net sales, which remained at ₹0.00 crore for two consecutive quarters. This stark situation contrasts sharply with the previous year, where minimal trading activity was recorded. The company reported a net profit of ₹0.68 crore, reflecting a decline of 31.31% quarter-on-quarter, driven largely by its reliance on other income, which accounted for ₹1.68 crore in the latest quarter. This other income represents a substantial 239.36% of profit before tax, underscoring the company's dependence on non-operating sources for its financial performance.\n\nThe operational metrics indicate that Transchem has not generated any meaningful sales since Q1 FY26, and its core business continues to incur losses, with an operating profit before depreciation, interest, and tax (excludin..."
      },
      {
        "title": "Transchem Ltd Q2 FY26: Operations Stalled, Other Income Props Up Profits",
        "link": "https://www.marketsmojo.com/news/result-analysis/transchem-ltd-q2-fy26-operations-stalled-other-income-props-up-profits-3826538",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/Transchem_quaterlyResult_3826538.png",
        "date": "2026-02-07 15:47:00",
        "description": "Transchem Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹204.00 crores, reported net profit of ₹0.68 crores for Q2 FY26, down 31.31% quarter-on-quarter from ₹0.99 crores in Q1 FY26. The company continues to face operational challenges, with zero sales recorded for the second consecutive quarter whilst remaining almost entirely dependent on other income to sustain profitability."
      },
      {
        "title": "When is the next results date for Transchem Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-transchem-ltd-3819098",
        "imagepath": "",
        "date": "2026-02-03 23:16:35",
        "description": "The next results date for Transchem Ltd is scheduled for 07 February 2026...."
      },
      {
        "title": "Transchem Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-downgraded-to-strong-sell-amid-mixed-technicals-and-weak-financials-3815561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TranschemLtd_mojoScore_3815561.png",
        "date": "2026-02-02 08:05:21",
        "description": "Transchem Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 February 2026. This adjustment reflects a complex interplay of deteriorating financial fundamentals, cautious valuation metrics, and nuanced technical signals, despite the company’s impressive long-term stock returns. Investors are urged to carefully consider these factors amid the evolving market landscape."
      },
      {
        "title": "Transchem Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-is-rated-sell-by-marketsmojo-3809104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TranschemLtd_mojoScore_3809104.png",
        "date": "2026-01-29 10:11:07",
        "description": "Transchem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with the latest insights into the company's performance and outlook."
      }
    ],
    "total": 170,
    "sid": "538955",
    "stock_news_url": "https://www.marketsmojo.com/news/transchem-538955"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Feb-2026",
      "details": "Please refer the attached intimation.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for The Meeting Held On February 07 2026 Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "07-Feb-2026",
      "details": "Please refer the attached intimation.",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 Along With Limited Review Report.",
      "datetime": "07-Feb-2026",
      "details": "Please refer the attached intimation.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Transchem Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Technical Signals

2026-03-03 08:07:39

Transchem Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 2 March 2026, reflecting a complex interplay of deteriorating financial fundamentals, cautious valuation metrics, and mixed technical signals. Despite impressive long-term returns, recent quarterly losses and weakening operational metrics have raised concerns among analysts, prompting a reassessment of the stock’s outlook.

Read full news article

Transchem Ltd Upgraded from Strong Sell to Sell Amid Mixed Technical and Financial Signals

2026-02-24 08:04:10

Transchem Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by improved technical indicators despite ongoing financial challenges. The pharmaceutical and biotechnology company’s recent performance reveals a complex picture where technical momentum contrasts with deteriorating fundamentals, prompting a nuanced reassessment of its investment appeal.

Read full news article

Transchem Ltd is Rated Strong Sell

2026-02-20 10:10:49

Transchem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 20 February 2026, providing investors with the most up-to-date insight into the stock’s fundamentals and market performance.

Read full news article

Transchem Ltd Investment Rating Upgraded to Sell on Technical Improvements

2026-02-09 08:03:07

Transchem Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 6 February 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing financial challenges, with the MarketsMOJO Mojo Score adjusting to 31.0. Investors are advised to consider the detailed analysis across quality, valuation, financial trends, and technical indicators before making decisions.

Read full news article

Are Transchem Ltd latest results good or bad?

2026-02-07 19:17:55

Transchem Ltd's latest financial results for Q2 FY26 reveal significant operational challenges, primarily characterized by a complete absence of net sales, which remained at ₹0.00 crore for two consecutive quarters. This stark situation contrasts sharply with the previous year, where minimal trading activity was recorded. The company reported a net profit of ₹0.68 crore, reflecting a decline of 31.31% quarter-on-quarter, driven largely by its reliance on other income, which accounted for ₹1.68 crore in the latest quarter. This other income represents a substantial 239.36% of profit before tax, underscoring the company's dependence on non-operating sources for its financial performance. The operational metrics indicate that Transchem has not generated any meaningful sales since Q1 FY26, and its core business continues to incur losses, with an operating profit before depreciation, interest, and tax (excludin...

Read full news article

Transchem Ltd Q2 FY26: Operations Stalled, Other Income Props Up Profits

2026-02-07 15:47:00

Transchem Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹204.00 crores, reported net profit of ₹0.68 crores for Q2 FY26, down 31.31% quarter-on-quarter from ₹0.99 crores in Q1 FY26. The company continues to face operational challenges, with zero sales recorded for the second consecutive quarter whilst remaining almost entirely dependent on other income to sustain profitability.

Read full news article

When is the next results date for Transchem Ltd?

2026-02-03 23:16:35

The next results date for Transchem Ltd is scheduled for 07 February 2026....

Read full news article

Transchem Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Financials

2026-02-02 08:05:21

Transchem Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 February 2026. This adjustment reflects a complex interplay of deteriorating financial fundamentals, cautious valuation metrics, and nuanced technical signals, despite the company’s impressive long-term stock returns. Investors are urged to carefully consider these factors amid the evolving market landscape.

Read full news article

Transchem Ltd is Rated Sell by MarketsMOJO

2026-01-29 10:11:07

Transchem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with the latest insights into the company's performance and outlook.

Read full news article

View All News